In contrast to the above reports of introducing αβ TCRs into γδ T cells, the Vγ9Vδ2 TCR has been transferred into αβ T cells and rendered both CD4+ and CD8+ T cells reactive to multiple tumor cell lines (93). Here, CD8A is linked to neoplasm.